Cargando…

In reply—Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research

Detalles Bibliográficos
Autores principales:	O’Horo, John C., Badley, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mayo Foundation for Medical Education and Research 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869676/ https://www.ncbi.nlm.nih.gov/pubmed/33814077 http://dx.doi.org/10.1016/j.mayocp.2021.02.005

Ejemplares similares

Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
por: Tai, Don Bambino Geno, et al.
Publicado: (2021)

Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
por: O’Horo, John Charles, et al.
Publicado: (2021)

Quality improvement and healthcare: The Mayo Clinic quality Academy experience
por: Comfere, Nneka I., et al.
Publicado: (2020)

In Reply—Repeated Testing in SARS-CoV-2 Infection
por: Shah, Aditya, et al.
Publicado: (2020)

344. Demographics of Patients with Brain Abscesses: A 10-year Mayo Clinic-Multicenter-Based Population Descriptive Study
por: Campioli, Cristina G Corsini, et al.
Publicado: (2020)

Multiomics single timepoint measurements to predict severe COVID-19 – Authors' reply
por: Garapati, Kishore, et al.
Publicado: (2023)

In Reply — Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019
por: Temesgen, Zelalem, et al.
Publicado: (2021)

Nasopharyngeal SARS-CoV-2 viral RNA shedding in patients with diabetes mellitus
por: Cano, Edison, et al.
Publicado: (2020)

Outcomes of Mayo Clinic reBoot camps for postimplementation training in the electronic health record
por: Gordon, Joel E, et al.
Publicado: (2022)

A Blueprint to Control the SARS-CoV-2 Pandemic
por: O’Horo, John C., et al.
Publicado: (2021)

Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience
por: Begna, K, et al.
Publicado: (2016)

Impact of the COVID-19 Pandemic on Respiratory Infection Rates
por: Cullinan, Susan M., et al.
Publicado: (2022)

Vaccination Safety: Don’t Toss the Champagne With the Cork
por: Shah, Aditya, et al.
Publicado: (2021)

Reply to “Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care”
por: Ather, Amber, et al.
Publicado: (2020)

Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
por: Pawlowski, Colin, et al.
Publicado: (2021)

Clinical Presentation and Outcome of Children with Brain Abscess: Author's Reply
por: Prasad, Rajniti, et al.
Publicado: (2021)

Reply to: The Impact of COVID-19 Pandemic on Scientific Research: an Upcoming New Wave?
por: Cosentino, Nicola, et al.
Publicado: (2023)

In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023)

Effects of Vaporized Hydrogen Peroxide Reprocessing on Quantitative Fit Performance of N95 Filtering Facepiece Respirators
por: Wengenack, Nancy L., et al.
Publicado: (2021)

Analytics and Prediction Modeling During the COVID-19 Pandemic
por: Challener, Douglas W., et al.
Publicado: (2020)

Volunteer effect and compromised randomization in the Mayo Project of screening for lung cancer
por: Dominioni, Lorenzo, et al.
Publicado: (2010)

In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes
por: Pawlowski, Colin, et al.
Publicado: (2022)

Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19
por: Yetmar, Zachary A., et al.
Publicado: (2021)

Reply to: “Clinical characteristics of COVID-19 patients with abnormal liver tests”
por: Cai, Qingxian, et al.
Publicado: (2020)

Antimicrobial prescribing practices at a tertiary-care center in patients diagnosed with COVID-19 across the continuum of care
por: Stevens, Ryan W., et al.
Publicado: (2020)

Authors' Reply to: COVID-19 as a “Force Majeure” for Non–COVID-19 Clinical and Translational Research. Comment on “Analysis of Scientific Publications During the Early Phase of the COVID-19 Pandemic: Topic Modeling Study”
por: Älgå, Andreas, et al.
Publicado: (2021)

Reply
por: Alvarez, Ronald D., et al.
Publicado: (2021)

Reply to “The outbreak of COVID-19: An overview”
por: Wu, Yi-Chi, et al.
Publicado: (2020)

Reply: CPET for Long COVID-19
por: Mancini, Donna M., et al.
Publicado: (2022)

Reply to the syndemic of “COVID-19 and tuberculosis”
por: Patil, Rajashri A., et al.
Publicado: (2023)

Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: López-Mendez, Ivan, et al.
Publicado: (2021)

Re: ‘Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review - authors' reply’
por: Serafim, Rodrigo B., et al.
Publicado: (2021)

In Reply
por: Fathi, Amir T., et al.
Publicado: (2016)

Critical Care Viral Infections
por: O'Horo, John C., et al.
Publicado: (2019)

Reply to Letter: factors affecting COVID-19 outcomes in patients with congenital heart disease
por: Jeilani, Hammad, et al.
Publicado: (2021)

Reply
por: Somasundaram, O.
Publicado: (1987)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

In reply—The “Perfect Cytokine Storm” of COVID-19
por: Vijayvargiya, Prakhar, et al.
Publicado: (2020)

Reply to “Novaferon, treatment in COVID-19 patients”
por: Zheng, Fang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_03p2j9ji8rinqd4nfdp05eng2n